TÜBİTAK National Metrology Institute (UME) is a key stakeholder representing Türkiye in the international ‘COMPASS’ project, which aims to protect the heart health of cancer patients and has received support from the European Commission.
The COMPASS Project, which aims to protect the heart health of patients undergoing cancer treatment and is carried out in partnership with TÜBİTAK National Metrology Institute (UME), has been awarded support under the Horizon Europe Program.
Cardiovascular conditions during or after cancer treatment pose a growing challenge for both patient health and healthcare systems. The late onset of these side effects and the scarcity of reliable markers (biomarkers) for early diagnosis make risk management difficult. This sometimes leads to a reduction in the dose of cancer treatment or even to complete discontinuation of treatment.
A Holistic Approach Centering the Patient
Developed to address this critical need, the COMPASS Project offers a patient-centered approach to protect the heart health of cancer patients and people in remission. The five-year project is building a strong international collaborative network for better prediction and early diagnosis of diseases.
TÜBİTAK UME Strengthens the Project with its Technological Infrastructure
TÜBİTAK National Metrology Institute (UME) is one of the most important stakeholders of the project. UME is making a major contribution to the project with its advanced measurement methods, reliable data generation and technological infrastructure competence. The project emphasizes artificial intelligence-supported imaging and wearable technologies to improve diagnostic methods and support personalized treatments. The project also aims to reduce the impact of healthcare services on the environment and to ensure sustainability.
Innovative Solutions
The COMPASS Project carries out its work through three main methods: the discovery of new clinical parameters, artificial intelligence prediction models and the development of clinical decision support systems. This process is supported by many side activities ranging from health economics to ethical aspects, from communication activities to sustainability.
67 Stakeholder Collaboration
The project group, which includes a total of 67 academic and industrial partners, aims to transfer the scientific results obtained directly to applications in hospitals. Doctors, nurses, patients and industry representatives form the basis of this large structure. The project aims to advance research in the field of cardio-oncology, while reducing healthcare costs and improving the quality of life of patients.
The fact that the COMPASS Project, in which UME is a partner within the scope of the Horizon Europe Program, is entitled to be supported by the European Commission strongly demonstrates the scientific and technological competence of our institution at the international level.
